A mid-sized, global pharmaceutical company is seeking novel formulation approaches and technologies that enable drug delivery for sustained periods. Specifically, the team is interested in approaches that allow for once weekly dosing from oral and transdermal delivered drugs, and long-acting injectable platforms (intravenous, intramuscular, and subcutaneous) that allow for a 4–6-month dosing regimen.
Submission of one-page, 200–300-word briefs is encouraged, along with any optional supplementary information e.g. relevant publications. In submitting to this campaign, you confirm that your submission contains only non-confidential information.
Our client is open to a range of collaboration opportunities, with the most appropriate outcome being decided on a case-by-case basis. Appropriate solutions will lead to a funded research and/or manufacturing collaboration of 1-2 years, with potential outcomes leading to licensing of assets, and investment. For earlier stage projects, research funding or PhD studentships may be available.
Technology
Academic Researcher
Centre of Excellence
Research Project
Spinout Company
Biotech Asset
Technology
Academic Researcher
Centre of Excellence
Research Project
Spinout Company
Biotech Asset
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.